Home / GLAXO.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does GLAXO.NS make money? Does GLAXO.NS have pricing power? What's the Earnings Whisper? Will GLAXO.NS profit more as the business scales? What is GLAXO.NS's management track record? Is GLAXO.NS's current price justified?

GlaxoSmithKline Pharmaceuticals Limited

₹2566.1 +$110.20 (+4.49%)

NSE · 16 Oct 2026 09:59 UTC

Previous Close

₹2524.7

Day Range

₹2518.4₹2573.2

Year Range

₹2088.1₹3120.7

Market Cap

434.71B

AVG Volume

115.32K

Trailing/Forward PE

40.7/31.93

PEG ratio

3.67

Dividend Yield

2.22%

Next Earnings Date

2026-11-03

Primary Exchange

National Stock Exchange of India

Revenue (INR) · A

GLAXO.NS Revenue (INR) by year
Period	Revenue (INR)
2026	38.22B
2025	37.26B
2024	34.42B
2023	32.26B
2022	32.64B
2021	31.08B
2020	31.99B
2019	30.99B

Net Income (INR) · A

GLAXO.NS Net Income (INR) by year
Period	Net Income (INR)
2026	10.36B
2025	9.28B
2024	5.9B
2023	6.11B
2022	16.95B
2021	3.58B
2020	932.05M
2019	4.45B

Operating Income (INR) · A

GLAXO.NS Operating Income (INR) by year
Period	Operating Income (INR)
2026	12.43B
2025	11.14B
2024	8.38B
2023	7.48B
2022	6.99B
2021	6.35B
2020	4.79B
2019	5.57B

EBITDA · A

Cash Flows · A

EPS · A

Expenses · A

Cash & Debt · A

Debt ratios · A

Margins · A

Return on Capital · A

Shares Outstanding · A

Dividends (INR) · A

Employee Count

Book Value Per Share · A

Total Assets · A

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

GlaxoSmithKline Pharmaceuticals Limited

Video analysis: GLAXO.NS

News: GLAXO.NS

Similar companies